We are live on ! Find out more
CF

C.T. Fitzpatrick Vulcan Value Partners

AUM $3.29B
1-Year Est. Return 6.08%
 

C.T. Fitzpatrick is the founder of Vulcan Value Partners, a firm that seeks high-quality businesses when they trade at discounts to estimated intrinsic value. Vulcan is known for a disciplined appraisal process and a willingness to hold cash when bargains are scarce. The firm’s equities strategies are widely followed in quality-value circles.

This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
-6.08%
3 Year Est. Return
+28.5%
5 Year Est. Return
+25.59%
10 Year Est. Return
+233.17%
AUM
$11.6B
AUM Growth
+$356M
Cap. Flow
-$328M
Cap. Flow %
-2.83%
Top 10 Hldgs %
46.02%
Holding
59
New
5
Increased
21
Reduced
29
Closed
4

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$180M
2
MCO icon
Moody's
MCO
+$177M
3
NTRS icon
Northern Trust
NTRS
+$153M
4
SPGI icon
S&P Global
SPGI
+$150M
5
SABR icon
Sabre
SABR
+$98.4M

Top Sells

Rank Stock Value
1
BEN icon
Franklin Templeton, Inc.
BEN
+$214M
2
ELV icon
Elevance Health
ELV
+$210M
3
SWKS icon
Skyworks Solutions
SWKS
+$146M
4
AXS icon
AXIS Capital
AXS
+$98.4M
5
EG icon
Everest Group
EG
+$96.2M

Sector Composition

Rank Sector Weight
1 Financials 28.86%
2 Healthcare 19.9%
3 Technology 19.5%
4 Consumer Discretionary 7.99%
5 Industrials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORCL icon
1
Oracle
ORCL
$422B
$1.01B 8.75%
22,708,953
+75,069
+0.3% +$3.13M
NOV icon
2
NOV
NOV
$7.28B
$661M 5.71%
16,488,429
+193,376
+1% +$7.54M
CVS icon
3
CVS Health
CVS
$119B
$596M 5.14%
7,586,549
+2,252,242
+42% +$180M
MCK icon
4
McKesson
MCK
$100B
$504M 4.35%
3,400,880
-60,314
-2% -$8.83M
COR icon
5
Cencora
COR
$60.7B
$472M 4.07%
5,329,275
-111,585
-2% -$9.81M
MA icon
6
Mastercard
MA
$509B
$435M 3.75%
3,865,633
+41,950
+1% +$4.6M
AXS icon
7
AXIS Capital
AXS
$7.2B
$434M 3.75%
6,475,573
-1,467,778
-18% -$98.4M
V icon
8
Visa
V
$693B
$420M 3.63%
4,731,398
-108,172
-2% -$9.31M
DISCK
9
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$409M 3.53%
14,453,035
+42,093
+0.3% +$1.15M
STT icon
10
State Street
STT
$51.4B
$386M 3.33%
4,848,047
-17,545
-0.4% -$1.39M
QRVO icon
11
Qorvo
QRVO
$8.43B
$383M 3.31%
5,584,735
-218,347
-4% -$14M
EG icon
12
Everest Group
EG
$14.2B
$365M 3.15%
1,560,031
-421,229
-21% -$96.2M
CAH icon
13
Cardinal Health
CAH
$53.4B
$350M 3.02%
4,291,200
-41,518
-1% -$3.27M
BA icon
14
Boeing
BA
$169B
$291M 2.51%
1,646,573
-213,950
-11% -$36.4M
ELV icon
15
Elevance Health
ELV
$86.9B
$286M 2.47%
1,730,750
-1,319,569
-43% -$210M
BNY
16
Bank of New York Mellon
BNY
$108B
$283M 2.45%
6,001,339
+87,582
+1% +$4.1M
CBRE icon
17
CBRE Group
CBRE
$44B
$281M 2.43%
8,084,900
+574,954
+8% +$19.2M
HLT icon
18
Hilton Worldwide
HLT
$73.5B
$254M 2.19%
4,341,075
-109,159
-2% -$6.34M
SWKS icon
19
Skyworks Solutions
SWKS
$10.1B
$233M 2.01%
2,374,361
-1,598,115
-40% -$146M
SABR icon
20
Sabre
SABR
$848M
$232M 2.01%
10,962,006
+4,296,056
+64% +$98.4M
AET
21
DELISTED
Aetna Inc
AET
$200M 1.73%
1,568,008
+173,255
+12% +$21.8M
FOSL icon
22
Fossil Group
FOSL
$332M
$199M 1.72%
11,387,845
+18,152
+0.2% +$385K
ACIW icon
23
ACI Worldwide
ACIW
$5.24B
$190M 1.64%
8,871,216
-283,437
-3% -$5.75M
MCO icon
24
Moody's
MCO
$87.2B
$185M 1.6%
+1,653,477
New +$177M
PH icon
25
Parker-Hannifin
PH
$126B
$179M 1.55%
1,117,459
-12,962
-1% -$1.97M
1
2 3

Similar funds

BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OCM
Oribel Capital Management New York $3.29B AUM 83.82% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.3B AUM 0.25% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

C.T. Fitzpatrick's Q1 2017 Portfolio in Review

As of Q1 2017, C.T. Fitzpatrick held 59 positions worth $11.6B, up 3.2% from $11.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

C.T. Fitzpatrick's Q1 2017 filing shows 5 new, 21 increased, 29 reduced and 4 closed positions. Its largest new stake was Moody's: 1,653,477 shares worth $185M. The largest sale was Franklin Templeton, Inc., an estimated $214M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

  • C.T. Fitzpatrick's largest Q1 2017 buy was Moody's: 1,653,477 shares worth $185M.
  • C.T. Fitzpatrick added most to CVS Health in Q1 2017, an estimated $180M increase.
  • C.T. Fitzpatrick's biggest Q1 2017 reduction was Elevance Health, cutting an estimated $210M.
  • C.T. Fitzpatrick fully exited Franklin Templeton, Inc. in Q1 2017, selling an estimated $214M.
  • C.T. Fitzpatrick's ten largest holdings make up 46% of its $11.6B portfolio in Q1 2017.
  • C.T. Fitzpatrick opened 5 new positions and closed 4 in Q1 2017.
  • C.T. Fitzpatrick's portfolio value rose 3.2% quarter-over-quarter to $11.6B.

Based on Vulcan Value Partners's 13F filing for Q1 2017, filed 15 May 2017.